Thyroid or Parathyroid Surgery
Conditions
Keywords
acupuncture, inflammation, thyroid, parathyroid
Brief summary
This study is being done because the investigators wish to study ways to improve recovery after surgery. Injury, including surgical injury, causes inflammation. Inflammation is the body's attempt to protect itself and to start the healing process. Some surgical complications are related to the body's natural inflammatory response. Although mainly a healing response, inflammation can also have side effects which delay recovery. The investigators wish to determine the effect of acupuncture on post-operative surgical pain. An increase in pain after surgery can cause distress for patients. Acupuncture is an alternative medicine methodology originating in China that treats patients by manipulating thin, solid needles that have been inserted into acupuncture points in the skin. Acupuncture has been used for the reduction of pain. The investigators would like to see if acupuncture during surgery can provide a lower level of pain, reduced pain medication requirement, and a lower incidence of nausea and vomiting.
Detailed description
Acupuncture has traditionally been used in Asia and is increasingly popular in Western countries to treat a variety of conditions (1). In recent years, acupuncture is widely used to assist in improving pain and inflammatory diseases (2). However, the mechanisms associated with these treatments that influence the immune system are not yet understood. Cytokines like interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) are proposed to be proximal mediators in the early stages of inflammation. They modulate many of the early inflammatory response that is induced by tissue injury, infection, or an immune stimulus (3, 4). Although the response is a critical first line of defense against pathogens, when the inflammatory reaction is uncontrolled, it can cause more damage to the host than the initial stimulus. TNF-α is a pro-inflammatory cytokine that is very effective in local and systemic inflammations (5). In addition, TNF-α increases the production of other inflammatory cytokines such as IL-1β, IL-6, and interleukin-18 (IL-18) during the inflammatory process. Therefore, it initially brings infections under control, produces coagulation in the damaged tissue, and stimulates tissue improvement. An excessive increase of TNF-α level causes an extreme immune reaction and contributes to the development of atherosclerosis, shock, endotoxemia, and chronic inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, and inflammatory bowel disease (5-7). Yim and colleagues reported a decrease in increased serum TNF-α, IL-6, and interferon gamma levels by arthritis as a result of electroacupuncture treatment (9). In a rat model for ulcerative colitis, acupuncture inhibited the expression of IL-1β and IL-6 (10). It has been reported that acupuncture significantly reduces complete Freund's adjuvant-induced hind paw edema and mouse air pouch inflammation (11, 12). Acupuncture could also improve immune dysfunction after surgical stress both in human and animals (13, 14). Some cytokines are pro-inflammatory, but others are anti-inflammatory (3). The anti-inflammatory interleukins comprise interleukine-4 (IL-4) and interleukine-10 (IL-10) and these are considered as mediating the down-regulation of immune-inflammatory conditions. Acupuncture for treatment of the ulcerative colitis rats is possibly related with the decrease of IL-1β, a pro-inflammatory cytokine, and the increase of IL-4, an anti-inflammatory cytokine (15). Therefore, it is reasonable to expect that the protective action of acupuncture is exerted by the modulation of pro- and anti-inflammatory cytokines. The restoration of balance between pro- and anti-inflammatory cytokines by acupuncture gives into the mechanisms underlying the immune-modulation effect of acupuncture. Inflammation is associated with pain hypersensitivity that is produced by the release of inflammatory mediators. The pro-inflammatory cytokines play an essential role in pain sensitization (16). The peripheral effects of these cytokines on sensitizing nociceptors have been well documented (16). Post-operative surgical pain can cause significant physiologic and psychologic distress for patients. An increase in pain duration and intensity after surgery can contribute to a variety of complications, including delayed ambulation, pulmonary and thromboembolic complications, increased length of hospital stay, and generalized distress and anxiety. Effective post-surgical pain relief requires a multidisciplinary effort and influences patients' satisfaction with care and successful outcomes (17). Acupuncture has been used for a long time for the reduction of pain. In light of these factors, the use of acupuncture that may allow a reduction in the dosage of conventional analgesics is highly valuable because it can lower the incidence of possible adverse effects. Several trials have demonstrated that patients receiving acupuncture prior to surgery have a lower level of pain, reduced opioid requirement, a lower incidence of post-operative nausea and vomiting, and lower sympatho-adrenal responses (18). The local release of β-endorphin could be responsible for the analgesic effect. β-endorphin may be interacting with cytokines to reduce pain and acupuncture may amplify the interaction between β-endorphin and cytokines. The investigators will ask patients undergoing thyroid and parathyroid surgery to determine how acupuncture restores a balance of pro- and anti-inflammatory cytokines to reduce pain and inflammation before, during, and after surgery. The effect of acupuncture on post-surgical pain will be evaluated. Protocol A prospective randomized, double-blinded (patient and data collector), study of 30 patients undergoing thyroid or parathyroid surgery under general anesthesia, will be conducted to compare the effects of acupuncture on the levels of circulating cytokines between acupuncture group and control group. The control group is to receive the same anesthetic and surgical techniques without the acupuncture. The principal investigator will use the Large intestine 4 (LI-4), the Large intestine 11 (LI-11), and the Stomach 36 (ST-36) acupuncture points (acupoints). LI-4 and LI-11 acupoints lie on the Large intestine meridian (pathway). The Large intestine meridian runs through the frontal neck region including the thyroid. LI-4 point is located in the middle of the 2nd metacarpal bone on the radial side and LI-11 point is located at the lateral end of the transverse cubital crease. Acupuncture on these two acupoints showed increased immune-modulatory effects including cytotoxicity of leukocytes (19, 20). ST-36 point is located on the outside of the anterior crest of the tibia and just below the knee. This point is the most commonly used to reduce general body pain (21). The acupuncture procedures will be performed by an anesthesiologist licensed to do so. After cleaning the skin with alcohol swabs, an acupuncture needle (30 Gauge, 0.30X30 millimeter, Mac Spring Handle Needle, Korea) will be swiftly inserted approximately 5-10 mm deep bilaterally at both LI-4 and LI-11 acupoints of each arm and at ST-36 acupoint of each leg. Electroacupuncture (EA) will be delivered by a stimulator (Digital Electronic Acupunctoscope 4-C, Model AWQ-104L™ Hong Kong, Dist by Lhasa Medical, Weymouth, MA) via electrodes from the stimulator at 10 Hz frequency with the electrical current of continuous wave. This setting showed significant anti-hyperalgesic effects in a rat inflammation model (22, 23) and also inhibited the up-regulation of IL-1β and its messenger Ribonucleic acid (mRNA) compared to the sham control in a rat model of bone cancer pain (24). EA is a particularly therapeutic method in which a small electrical charge is applied to acupuncture needles inserted at the acupoints. EA has the advantage of combining the stimulation of both needles and electricity compared to manual acupuncture alone, and may potentiate the effect of the acupuncture treatment along the meridians. One end of electrode will be attached to the acupuncture needle handle at LI-4 acupoint, and another end will be attached to the acupuncture needle handle at LI-11acupoint bilaterally. For EA on ST-36, one end of electrode will be attached at the right side ST-36 acupoint and another end will be attached at the left side ST-36 acupoint. A symmetrical biphasic wave will be delivered to the electrodes so that the electrode will be alternately positive and negative and the bilateral LI-4, LI-11, and ST-36 acupoints will be stimulated alternately. Mild muscle twitching will be observed. The investigator will stimulate the acupoints as follows: 1. EA will be performed for 30 min (a time that is similar to that used in clinical practice). 2. EA will stop after 30 min of the treatment, but leave the needles on the acupoints. 3. Subsequently, EA will be re-initiated for an additional 30 min. This advanced EA technique showed more increased nitric oxide production in the second interval of EA than that of the first interval, and reduced blood pressure at the end of the second interval in our preliminarily study (25). In addition, this technique increased transient receptor potential vanilloid type-1 receptor immunoreactivity in the acupoints compared to that of non-acupoints (26). The advanced EA treatment will be started just before the beginning of surgery. At the conclusion of the surgical procedure, the acupuncture needles will be removed. The subjects will be awakened and after meeting the criteria for extubation will be transferred to the Post Anesthesia Care Unit (PACU). Blood Samples A second intravenous line will be placed in the other arm after the induction of anesthesia and prior to surgical incision to collect blood samples. 15 ml of blood will be collected at three time points: (1) preinduction, (2) just after the advanced EA treatment (3) after arrival in PACU and prior to additional medication administration (approximately 120 minutes post preinduction sample). These specimens will be placed into vacutainer tubes with no anti-coagulant. Blood will be drawn with a syringe attached directly to the angiocatheter which has been placed intravenously. To prevent hemolysis, blood will be transferred without a needle, to a vacutainer whose top has been removed. The vacutainer top will be replaced and specimens labeled with study name, subject's study ID number, sample number, and dated. Bloods from the first two time points will be kept refrigerated until the final sample is obtained postoperatively. Blood samples will be transported to the Institute for Complementary and Alternative Medicine/School of Health Related Professions Interprofessional Health Research Laboratory within the Department of Clinical Lab Sciences (G level, Bergen Building, 65 Bergen St., Newark). They will be centrifuged, serum removed, aliquoted, and stored at -80C until analysis. Laboratory Analysis Samples will be analyzed for levels of cortisol, C-reactive proteins, and cytokines interleukin (IL)-1α, IL-1β, IL-1ra, IL-2, IL-6, IL-8, IL-10, and TNF-α, by appropriate methods, including ELISA or multiplex fluorescent bead technology. All samples will be run in duplicate on with plates and reagents of the same lot. In addition we will test Adrenocorticotropic hormone (ACTH), glucose and insulin to evaluate the response of the stress. Any samples varying greater than 15% between duplicates will be repeated.
Interventions
One half of subjects will receive a standardized acupuncture regiment
placebo
Sponsors
Study design
Eligibility
Inclusion criteria
1. Not currently pregnant or beast feeding 2. American Society of Anesthesiologists physical status of 1, 2, 3 as determined by your anesthesiologist 3. Patients have a working telephone
Exclusion criteria
1. Uncontrolled high blood pressure (systolic \> 180 mm Hg (millimeters of mercury), diastolic\>110 mm Hg 2. Heart block \>than first degree 3. Pacemaker 4. Cardiac muscle is at risk for injury 5. not English speaking 6. Acupuncture within the last 30 days 7. If you have taken ibuprofen, advil aleve, motrin or aspirin with 5 days of the scheduled surgery. 8. Prior history of drug or alcohol dependence 9. If you are unable to feed, dress or bathe yourself 10. If your breathing tube is not removed prior to leaving the operating room.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduced Pain Medication Requirement | amount of pain medication provided in PACU | analgesia provided in Post Anesthesia Care Unit PACU) |
| Visual Acuity Score (VAS) | arrival in PACU to 2 hours post operatively | VAS is a self reported pain scale with a score ranging from 0 to 10. 0= no pain, 10=worst pain possible. Multiple pain sacores were recorded. single value is reported by average |
| Morphine Equivalent | PACU, day 1 , day 2, day 3 | equivalent doses of morphine for analgesic relief. All analgesic treatments were converted to morphine equivalents in milligrams. |
| Pain Levels | PACU, day 1 , day 2, day 3 | Visual Acuity scale 0=no pain 10= worst pain possible |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cortisol | prior to surgical incision, 1 hour following incision, after arrival in PACU | All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia. |
| Glucose | serum glucose from baseline to PACU arrival | the first two blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia. |
| Tumor Necrosis Factor (TNF) | preoperatively-intraoperatively-postoperatively | First two blood samples were collected during general anesthesia, first prior to surgical incision and Electro-acupuncture (EA), 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia. TNF is a critical pyrogen produced during acute phase of a reaction to trauma. |
| iNTERLEUKIN (IL-2 and IL-4) | Preoperatively-intraoperatively-postoperatively | both are IL-2 and IL-4 are critical cytokines regulating the cellular response to induce cellular versus hormone immunity. First two blood samples were collected during general anesthesia: first prior to surgical incision and electroacupuncture, second 60 minutes after incision and electroacupuncture and the 3rd after arrival in PACU but before analgesia. |
| (ACTH )Adrenocorticotropic Hormone | serum ACTH from baseline/preoperatively,intraoperatively, upon arrival in PACU | All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia. The data below represents female patients only |
| IL-10 | Preoperatively-intraoperatively-postoperatively | IL-10 is an anti-inflammatory cytokine marker. First two blood samples were collected during general anesthesia, first prior to surgical incision and EA, 2nd 60 minutes following incision and EA, and the third after arrival in PACU but before administration of analgesia. |
| TGFB1 | Preoperatively-intraoperatively-postoperatively | TGFB1 is a pleiotropic factor regulating the immune system and healing. First two blood samples drawn under general anesthesia, first prior to surgical incision and EA, the 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia. |
| Serum Insulin Level | preoperative and postoperative | to determine if electroacupuncture reduced hyperglycemia |
| IL-6 | Preoperatively-intraoperatively-postoperatively | First two blood samples were collected during general anesthesia, first prior to Surgical incision and EA, 2nd 60 minutes after incision and EA and the 3rd after arrival in PACU but before administration of analgesia. IL-6 is a critical inflammatory cytokine produced during the acute phase of reaction to trauma |
| Morphine Equivalent | PACU to 2 hours post op | All analgesic treatments were converted to morphine equivalents in milligrams . |
| Morphine Equivalent (mg) | PACU arrival to 2 hours post op | morphine equivalent to analyze whether body weight affected the efficacy of electroacupuncture |
| Modified Quality of Recovery Scale | Day 1, 2, 3 | Modified patient self reported scale with 9 questions regarding general well being including ability to eat, free from constant pain, able to manage activities of daily living. 0= worst possible score and 18=best outcome score |
Countries
United States
Participant flow
Recruitment details
Participants were recruited in a Same Day Surgery Suite at a academic medical center. The first participant was enrolled on 7/2/13 and last patient enrolled on 7/15/14.
Participants by arm
| Arm | Count |
|---|---|
| Acupuncture acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment | 11 |
| Sham/Placebo no acupuncture will be done on this group of subjects. Since they are under general anesthesia they will not realize they are acting as control group
no acupuncture: placebo | 9 |
| Total | 20 |
Baseline characteristics
| Characteristic | Acupuncture | Sham/Placebo | Total |
|---|---|---|---|
| Age, Customized <45 years | 6 participants | 2 participants | 8 participants |
| Age, Customized 45 years or older | 5 participants | 7 participants | 12 participants |
| Region of Enrollment United States | 11 participants | 9 participants | 20 participants |
| Sex: Female, Male Female | 9 Participants | 9 Participants | 18 Participants |
| Sex: Female, Male Male | 2 Participants | 0 Participants | 2 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 11 | 0 / 9 |
| serious Total, serious adverse events | 0 / 11 | 0 / 9 |
Outcome results
Morphine Equivalent
equivalent doses of morphine for analgesic relief. All analgesic treatments were converted to morphine equivalents in milligrams.
Time frame: PACU, day 1 , day 2, day 3
Population: since gender impacts the threshold for analgesic and pain the effects of electroacupuncture on females was analyzed. The same number of females were in both groups but since one subject had preexisting levels of TNF\>1ug/ml prior to surgery she was eliminated from the dta base
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | Morphine Equivalent | PACU | 3.19 mg morphine | Standard Error 1.59 |
| Acupuncture | Morphine Equivalent | Day 1 | 6.31 mg morphine | Standard Error 2.14 |
| Acupuncture | Morphine Equivalent | Day 2 | 9.84 mg morphine | Standard Error 3.44 |
| Acupuncture | Morphine Equivalent | Day 3 | 7.93 mg morphine | Standard Error 3.35 |
| Sham/Placebo | Morphine Equivalent | Day 3 | 5.25 mg morphine | Standard Error 2.32 |
| Sham/Placebo | Morphine Equivalent | PACU | 7.36 mg morphine | Standard Error 1.49 |
| Sham/Placebo | Morphine Equivalent | Day 2 | 7.42 mg morphine | Standard Error 2.37 |
| Sham/Placebo | Morphine Equivalent | Day 1 | 9 mg morphine | Standard Error 2.44 |
Pain Levels
Visual Acuity scale 0=no pain 10= worst pain possible
Time frame: PACU, day 1 , day 2, day 3
Population: female patients self reported pain experience following surgery
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | Pain Levels | PACU | 4.88 units on a scale | Standard Error 1.29 |
| Acupuncture | Pain Levels | Day 1 | 6.67 units on a scale | Standard Error 1.09 |
| Acupuncture | Pain Levels | day2 | 5 units on a scale | Standard Error 1.09 |
| Acupuncture | Pain Levels | day3 | 4.28 units on a scale | Standard Error 0.95 |
| Sham/Placebo | Pain Levels | day3 | 3.33 units on a scale | Standard Error 0.96 |
| Sham/Placebo | Pain Levels | PACU | 6.67 units on a scale | Standard Error 1.01 |
| Sham/Placebo | Pain Levels | day2 | 5.93 units on a scale | Standard Error 0.49 |
| Sham/Placebo | Pain Levels | Day 1 | 5.56 units on a scale | Standard Error 0.96 |
Reduced Pain Medication Requirement
analgesia provided in Post Anesthesia Care Unit PACU)
Time frame: amount of pain medication provided in PACU
Population: All subjects enrolled in study
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Acupuncture | Reduced Pain Medication Requirement | 5.43 mg of Morphine | Standard Error 1.7 |
| Sham/Placebo | Reduced Pain Medication Requirement | 7.36 mg of Morphine | Standard Error 1.49 |
Visual Acuity Score (VAS)
VAS is a self reported pain scale with a score ranging from 0 to 10. 0= no pain, 10=worst pain possible. Multiple pain sacores were recorded. single value is reported by average
Time frame: arrival in PACU to 2 hours post operatively
Population: all study participants
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Acupuncture | Visual Acuity Score (VAS) | 5.36 units on a scale | Standard Error 0.97 |
| Sham/Placebo | Visual Acuity Score (VAS) | 6.67 units on a scale | Standard Error 1.01 |
(ACTH )Adrenocorticotropic Hormone
All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia. The data below represents female patients only
Time frame: serum ACTH from baseline/preoperatively,intraoperatively, upon arrival in PACU
Population: females
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | (ACTH )Adrenocorticotropic Hormone | postoperative | 53.36 pg/ml | Standard Error 33.84 |
| Acupuncture | (ACTH )Adrenocorticotropic Hormone | postop>45 years | 19.4 pg/ml | Standard Error 8.09 |
| Acupuncture | (ACTH )Adrenocorticotropic Hormone | intraoperative | 15.26 pg/ml | Standard Error 12.13 |
| Acupuncture | (ACTH )Adrenocorticotropic Hormone | postop<75kg | 15.03 pg/ml | Standard Error 5.85 |
| Acupuncture | (ACTH )Adrenocorticotropic Hormone | post op<45years | 110 pg/ml | Standard Error 88.94 |
| Acupuncture | (ACTH )Adrenocorticotropic Hormone | postop>75 kg | 83.48 pg/ml | Standard Error 68.23 |
| Acupuncture | (ACTH )Adrenocorticotropic Hormone | preoperative | 8.56 pg/ml | Standard Error 2.6 |
| Sham/Placebo | (ACTH )Adrenocorticotropic Hormone | postop>75 kg | 376.2 pg/ml | Standard Error 73.39 |
| Sham/Placebo | (ACTH )Adrenocorticotropic Hormone | preoperative | 21.32 pg/ml | Standard Error 7.08 |
| Sham/Placebo | (ACTH )Adrenocorticotropic Hormone | intraoperative | 21.41 pg/ml | Standard Error 8.3 |
| Sham/Placebo | (ACTH )Adrenocorticotropic Hormone | postoperative | 202 pg/ml | Standard Error 74.37 |
| Sham/Placebo | (ACTH )Adrenocorticotropic Hormone | post op<45years | 276.1 pg/ml | Standard Error 221.9 |
| Sham/Placebo | (ACTH )Adrenocorticotropic Hormone | postop>45 years | 177.3 pg/ml | Standard Error 80.96 |
| Sham/Placebo | (ACTH )Adrenocorticotropic Hormone | postop<75kg | 27.85 pg/ml | Standard Error 14.35 |
Cortisol
All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.
Time frame: prior to surgical incision, 1 hour following incision, after arrival in PACU
Population: females
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | Cortisol | intraoperative | 103.1 ng/ml | Standard Error 19.93 |
| Acupuncture | Cortisol | postoperative>45 years | 202.4 ng/ml | Standard Error 61.55 |
| Acupuncture | Cortisol | preoperative | 173.6 ng/ml | Standard Error 83.3 |
| Acupuncture | Cortisol | postoperative<75 kg | 252.1 ng/ml | Standard Error 88.76 |
| Acupuncture | Cortisol | postoperative<45 years | 375.6 ng/ml | Standard Error 229.1 |
| Acupuncture | Cortisol | postoperative>75 kg | 296 ng/ml | Standard Error 180.5 |
| Acupuncture | Cortisol | postoperative | 267.4 ng/ml | Standard Error 89.33 |
| Sham/Placebo | Cortisol | postoperative>75 kg | 618.1 ng/ml | Standard Error 114.6 |
| Sham/Placebo | Cortisol | postoperative | 394.4 ng/ml | Standard Error 104.6 |
| Sham/Placebo | Cortisol | preoperative | 155.2 ng/ml | Standard Error 40.37 |
| Sham/Placebo | Cortisol | intraoperative | 145.2 ng/ml | Standard Error 26.85 |
| Sham/Placebo | Cortisol | postoperative<45 years | 480 ng/ml | Standard Error 302.1 |
| Sham/Placebo | Cortisol | postoperative>45 years | 365.8 ng/ml | Standard Error 116.9 |
| Sham/Placebo | Cortisol | postoperative<75 kg | 170.7 ng/ml | Standard Error 67.28 |
Glucose
the first two blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.
Time frame: serum glucose from baseline to PACU arrival
Population: females
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | Glucose | postop <75 kg | 144.3 mg/dL | Standard Error 7.22 |
| Acupuncture | Glucose | preoperative | 150.4 mg/dL | Standard Error 11.36 |
| Acupuncture | Glucose | intraoperative | 154.3 mg/dL | Standard Error 8.75 |
| Acupuncture | Glucose | postoperative | 152.8 mg/dL | Standard Error 7.76 |
| Acupuncture | Glucose | post op < 45 years | 154.7 mg/dL | Standard Error 9.39 |
| Acupuncture | Glucose | post op > 45 years | 151.6 mg/dL | Standard Error 11.88 |
| Acupuncture | Glucose | post op >75 kg | 148.5 mg/dL | Standard Error 9.06 |
| Sham/Placebo | Glucose | postop <75 kg | 210.3 mg/dL | Standard Error 32.46 |
| Sham/Placebo | Glucose | post op < 45 years | 190 mg/dL | Standard Error 26 |
| Sham/Placebo | Glucose | preoperative | 164.4 mg/dL | Standard Error 10.94 |
| Sham/Placebo | Glucose | post op >75 kg | 206.4 mg/dL | Standard Error 2.98 |
| Sham/Placebo | Glucose | intraoperative | 187.1 mg/dL | Standard Error 15.82 |
| Sham/Placebo | Glucose | post op > 45 years | 213.3 mg/dL | Standard Error 15.93 |
| Sham/Placebo | Glucose | postoperative | 208.1 mg/dL | Standard Error 13.36 |
IL-10
IL-10 is an anti-inflammatory cytokine marker. First two blood samples were collected during general anesthesia, first prior to surgical incision and EA, 2nd 60 minutes following incision and EA, and the third after arrival in PACU but before administration of analgesia.
Time frame: Preoperatively-intraoperatively-postoperatively
Population: total females; then those grouped by age (\<45years and\>45 years) and weight (\<75 Kg and \>75kg)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | IL-10 | IL-10 postoperative | 16.15 pg/ml | Standard Error 9.4 |
| Acupuncture | IL-10 | IL-10>75kg postop | 32.18 pg/ml | Standard Error 26.58 |
| Acupuncture | IL-10 | IL-10 preoperatively | 5.35 pg/ml | Standard Error 0.93 |
| Acupuncture | IL-10 | IL_10 intraoperative | 7.28 pg/ml | Standard Error 1.62 |
| Acupuncture | IL-10 | IL-10 <45 yrs postop | 40.23 pg/ml | Standard Error 13.64 |
| Acupuncture | IL-10 | IL-10 >45 postop | 7.7 pg/ml | Standard Error 1.19 |
| Acupuncture | IL-10 | IL-10 <75kg postop | 8.6 pg/ml | Standard Error 1.6 |
| Sham/Placebo | IL-10 | IL-10>75kg postop | 20.47 pg/ml | Standard Error 6.1 |
| Sham/Placebo | IL-10 | IL-10 <45 yrs postop | 13.64 pg/ml | Standard Error 10.07 |
| Sham/Placebo | IL-10 | IL-10 <75kg postop | 10.7 pg/ml | Standard Error 4.46 |
| Sham/Placebo | IL-10 | IL-10 preoperatively | 6.0 pg/ml | Standard Error 0.8 |
| Sham/Placebo | IL-10 | IL-10 >45 postop | 16.86 pg/ml | Standard Error 4.8 |
| Sham/Placebo | IL-10 | IL_10 intraoperative | 7.81 pg/ml | Standard Error 2.22 |
| Sham/Placebo | IL-10 | IL-10 postoperative | 16.14 pg/ml | Standard Error 4.07 |
IL-6
First two blood samples were collected during general anesthesia, first prior to Surgical incision and EA, 2nd 60 minutes after incision and EA and the 3rd after arrival in PACU but before administration of analgesia. IL-6 is a critical inflammatory cytokine produced during the acute phase of reaction to trauma
Time frame: Preoperatively-intraoperatively-postoperatively
Population: total female results; then females divided into age groups (\<45 or \>45years) and weights groups (\<75kg and \>75kg)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | IL-6 | IL-6 postoperatively | 26.96 pg/ml | Standard Error 10.35 |
| Acupuncture | IL-6 | IL-6 >45 yrs postop | 29.28 pg/ml | Standard Error 16.97 |
| Acupuncture | IL-6 | IL-6 intraoperatively | 4.98 pg/ml | Standard Error 1.1 |
| Acupuncture | IL-6 | IL-6 <75 kg postop | 37.15 pg/ml | Standard Error 28.41 |
| Acupuncture | IL-6 | IL-6 <45 yrs post op | 23.10 pg/ml | Standard Error 5.3 |
| Acupuncture | IL-6 | IL-6 >75 kg postop | 25.44 pg/ml | Standard Error 4.47 |
| Acupuncture | IL-6 | IL-6 preoperatively | 3.58 pg/ml | Standard Error 0.92 |
| Sham/Placebo | IL-6 | IL-6 >75 kg postop | 36.61 pg/ml | Standard Error 12.95 |
| Sham/Placebo | IL-6 | IL-6 preoperatively | 4.65 pg/ml | Standard Error 0.34 |
| Sham/Placebo | IL-6 | IL-6 intraoperatively | 4.66 pg/ml | Standard Error 0.4 |
| Sham/Placebo | IL-6 | IL-6 postoperatively | 27.45 pg/ml | Standard Error 7.85 |
| Sham/Placebo | IL-6 | IL-6 <45 yrs post op | 30.9 pg/ml | Standard Error 6.9 |
| Sham/Placebo | IL-6 | IL-6 >45 yrs postop | 26.46 pg/ml | Standard Error 10.14 |
| Sham/Placebo | IL-6 | IL-6 <75 kg postop | 16 pg/ml | Standard Error 3.4 |
iNTERLEUKIN (IL-2 and IL-4)
both are IL-2 and IL-4 are critical cytokines regulating the cellular response to induce cellular versus hormone immunity. First two blood samples were collected during general anesthesia: first prior to surgical incision and electroacupuncture, second 60 minutes after incision and electroacupuncture and the 3rd after arrival in PACU but before analgesia.
Time frame: Preoperatively-intraoperatively-postoperatively
Population: all females
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | iNTERLEUKIN (IL-2 and IL-4) | IL-2preoperative | 2.64 pg/ml | Standard Error 1.53 |
| Acupuncture | iNTERLEUKIN (IL-2 and IL-4) | IL-2 postoperative | 2.33 pg/ml | Standard Error 1.31 |
| Acupuncture | iNTERLEUKIN (IL-2 and IL-4) | IL-4 postoperative | 0.41 pg/ml | Standard Error 0.12 |
| Acupuncture | iNTERLEUKIN (IL-2 and IL-4) | IL-4 preoperative | 0.52 pg/ml | Standard Error 0.15 |
| Acupuncture | iNTERLEUKIN (IL-2 and IL-4) | IL-2intraoperative | 2.38 pg/ml | Standard Error 1.3 |
| Acupuncture | iNTERLEUKIN (IL-2 and IL-4) | IL-4 intraoperative | 0.57 pg/ml | Standard Error 0.27 |
| Sham/Placebo | iNTERLEUKIN (IL-2 and IL-4) | IL-2intraoperative | 3.4 pg/ml | Standard Error 2.87 |
| Sham/Placebo | iNTERLEUKIN (IL-2 and IL-4) | IL-4 postoperative | 0.37 pg/ml | Standard Error 0.1 |
| Sham/Placebo | iNTERLEUKIN (IL-2 and IL-4) | IL-2preoperative | 4.26 pg/ml | Standard Error 3.62 |
| Sham/Placebo | iNTERLEUKIN (IL-2 and IL-4) | IL-4 intraoperative | 0.56 pg/ml | Standard Error 0.28 |
| Sham/Placebo | iNTERLEUKIN (IL-2 and IL-4) | IL-2 postoperative | 2.77 pg/ml | Standard Error 2.24 |
| Sham/Placebo | iNTERLEUKIN (IL-2 and IL-4) | IL-4 preoperative | 0.59 pg/ml | Standard Error 0.25 |
Modified Quality of Recovery Scale
Modified patient self reported scale with 9 questions regarding general well being including ability to eat, free from constant pain, able to manage activities of daily living. 0= worst possible score and 18=best outcome score
Time frame: Day 1, 2, 3
Population: all females
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | Modified Quality of Recovery Scale | Day 1 | 14.5 units on a scale | Standard Error 0.98 |
| Acupuncture | Modified Quality of Recovery Scale | Day 2 | 16 units on a scale | Standard Error 0.73 |
| Acupuncture | Modified Quality of Recovery Scale | Day 3 | 17.57 units on a scale | Standard Error 0.3 |
| Sham/Placebo | Modified Quality of Recovery Scale | Day 1 | 13.33 units on a scale | Standard Error 0.85 |
| Sham/Placebo | Modified Quality of Recovery Scale | Day 2 | 15.89 units on a scale | Standard Error 0.75 |
| Sham/Placebo | Modified Quality of Recovery Scale | Day 3 | 17 units on a scale | Standard Error 0.33 |
Morphine Equivalent
All analgesic treatments were converted to morphine equivalents in milligrams .
Time frame: PACU to 2 hours post op
Population: females grouped by age (\<45 years and 45 years or greater)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | Morphine Equivalent | > 45 years old | 3.9 mg of Morphine | Standard Error 2.52 |
| Acupuncture | Morphine Equivalent | < 45 years old | 2 mg of Morphine | Standard Error 1.16 |
| Sham/Placebo | Morphine Equivalent | > 45 years old | 6.68 mg of Morphine | Standard Error 1.76 |
| Sham/Placebo | Morphine Equivalent | < 45 years old | 9.75 mg of Morphine | Standard Error 2.75 |
Morphine Equivalent (mg)
morphine equivalent to analyze whether body weight affected the efficacy of electroacupuncture
Time frame: PACU arrival to 2 hours post op
Population: females with body weight \<75 kg and \>than 75 kg
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | Morphine Equivalent (mg) | <75 kg | 3.25 mg morphine | Standard Error 2.38 |
| Acupuncture | Morphine Equivalent (mg) | >75 kg | 4.63 mg morphine | Standard Error 2.63 |
| Sham/Placebo | Morphine Equivalent (mg) | <75 kg | 9.69 mg morphine | Standard Error 1.48 |
| Sham/Placebo | Morphine Equivalent (mg) | >75 kg | 5.5 mg morphine | Standard Error 2.17 |
Serum Insulin Level
to determine if electroacupuncture reduced hyperglycemia
Time frame: preoperative and postoperative
Population: female subjects preoperatively and postoperatively
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | Serum Insulin Level | preoperative | 257.4 pg/ml | Standard Error 92.8 |
| Acupuncture | Serum Insulin Level | postoperative | 311.2 pg/ml | Standard Error 50.59 |
| Sham/Placebo | Serum Insulin Level | preoperative | 378.1 pg/ml | Standard Error 95.05 |
| Sham/Placebo | Serum Insulin Level | postoperative | 325.4 pg/ml | Standard Error 84.46 |
TGFB1
TGFB1 is a pleiotropic factor regulating the immune system and healing. First two blood samples drawn under general anesthesia, first prior to surgical incision and EA, the 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia.
Time frame: Preoperatively-intraoperatively-postoperatively
Population: all females; then females by groups age (\<45 years and \>45 years) and weight (\<75kg and \>75kg)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | TGFB1 | >75kg postop | 21.3 pg/ml | Standard Error 9.2 |
| Acupuncture | TGFB1 | preoperative | 7.30 pg/ml | Standard Error 3.5 |
| Acupuncture | TGFB1 | intraoperative | 19.5 pg/ml | Standard Error 6.28 |
| Acupuncture | TGFB1 | postoperative | 35.17 pg/ml | Standard Error 8.8 |
| Acupuncture | TGFB1 | <45 yrs post op | 16.76 pg/ml | Standard Error 11.37 |
| Acupuncture | TGFB1 | >45 yrs postop | 46.2 pg/ml | Standard Error 9.9 |
| Acupuncture | TGFB1 | <75 kg postop | 56.76 pg/ml | Standard Error 13.51 |
| Sham/Placebo | TGFB1 | >75kg postop | 12.11 pg/ml | Standard Error 2.73 |
| Sham/Placebo | TGFB1 | <45 yrs post op | 4.89 pg/ml | Standard Error 0.48 |
| Sham/Placebo | TGFB1 | preoperative | 3.26 pg/ml | Standard Error 1.53 |
| Sham/Placebo | TGFB1 | <75 kg postop | 13.96 pg/ml | Standard Error 5.39 |
| Sham/Placebo | TGFB1 | intraoperative | 9.4 pg/ml | Standard Error 3.5 |
| Sham/Placebo | TGFB1 | >45 yrs postop | 15.2 pg/ml | Standard Error 2.8 |
| Sham/Placebo | TGFB1 | postoperative | 12.9 pg/ml | Standard Error 2.65 |
Tumor Necrosis Factor (TNF)
First two blood samples were collected during general anesthesia, first prior to surgical incision and Electro-acupuncture (EA), 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia. TNF is a critical pyrogen produced during acute phase of a reaction to trauma.
Time frame: preoperatively-intraoperatively-postoperatively
Population: female subjects
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Acupuncture | Tumor Necrosis Factor (TNF) | intraoperative | 2.09 pg/ml | Standard Error 0.62 |
| Acupuncture | Tumor Necrosis Factor (TNF) | postoperative | 1.98 pg/ml | Standard Error 1 |
| Acupuncture | Tumor Necrosis Factor (TNF) | preoperatively | 1.88 pg/ml | Standard Error 0.67 |
| Sham/Placebo | Tumor Necrosis Factor (TNF) | preoperatively | 2.14 pg/ml | Standard Error 0.63 |
| Sham/Placebo | Tumor Necrosis Factor (TNF) | intraoperative | 2.25 pg/ml | Standard Error 0.74 |
| Sham/Placebo | Tumor Necrosis Factor (TNF) | postoperative | 1.9 pg/ml | Standard Error 0.7 |